Related Experiment Video
Updated: Mar 2, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
ABCB1-Gen-Polymorphismus in einer polnischen Kohorte ist mit Risiko für bullöses Pemphigoid assoziiert
Mariola Rychlik-Sych1, Małgorzata Barańska1, Michał Dudarewicz1
1Department of Pharmacogenetics, Chair of Biopharmacy, Medical University of Lodz, Łódz´, Polen.
Genetic variations in the ABCB1 gene, specifically the G2677T/A polymorphism, are linked to an increased risk of developing bullous pemphigoid (BP). The 2677G allele may offer a protective effect against BP development.
Area of Science:
- Genetics
- Immunodermatology
- Pharmacogenomics
Background:
- ABCB1 gene polymorphisms can affect xenobiotic concentrations, potentially contributing to autoimmune diseases like bullous pemphigoid (BP).
- Investigating the association between ABCB1 gene variants and BP risk is crucial for understanding disease pathogenesis.
Purpose of the Study:
- To examine the association of ABCB1 gene C3435T and G2677T/A polymorphisms with the risk of developing bullous pemphigoid (BP) in a Polish cohort.
Main Methods:
- The study included 71 BP patients and 156 healthy controls.
- C3435T polymorphism was analyzed using PCR-RFLP.
- G2677T/A polymorphism was determined via allele-specific PCR.
Main Results:
- No significant correlation was found between the C3435T polymorphism and BP risk.
- The G2677T/A polymorphism showed a significant association with BP risk.
- Individuals with the 2677TA genotype had over a fivefold increased risk (OR=5.52), and 2677TT genotype carriers had more than double the risk (OR=2.40).
- The 2677T allele also showed an increased risk (OR=2.40).
- The 2677GG genotype and 2677G allele were more prevalent in controls, suggesting a protective role (OR<1.0).
Conclusions:
- The G2677T/A polymorphism in the ABCB1 gene may influence the risk of developing bullous pemphigoid.
- The 2677G allele might confer a protective effect against BP.
Related Concept Videos
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenomics: Identification of New Drug Targets
Pedigree Analysis
The ABO Blood Group
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...

